News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Zeinab Tarhini: The 10th International Course of Neuroepidemiology
Zeinab Tarhini/LinkedIn
Nov 28, 2024, 17:28

Zeinab Tarhini: The 10th International Course of Neuroepidemiology

Zeinab Tarhini, Postdoctoral Researcher at Université Grenoble Alpes, shared a post on LinkedIn:

“The 10th International Course of Neuroepidemiology: Methods and Clinical Applications at the Ettore Majorana Foundation and Center for Scientific Culture ets in Erice, Italy.”

Zeinab Tarhini: The 10th International Course of Neuroepidemiology

For more Updates, Follow OncoDaily.

cancer Ettore Majorana Foundation Italy Neuroepidemiology OncoDaily Oncology Université Grenoble Alpes Zeinab Tarhini
Special Coverage
Blog
Nov 28, 2024, 17:28
Zeinab Tarhini: The 10th International Course of Neuroepidemiology
Blog
Nov 28, 2024, 17:24
Russell Conley's loss will no doubt be felt deeply across the GI Cancer Community
Insight
Nov 28, 2024, 17:18
Richard Sullivan: Do we need a 'new' Geneva Convention and protocols?
Insight
Nov 28, 2024, 17:16
Rami Manochakian: Apply for the 2025 IASLC Academy
Blog
Nov 28, 2024, 17:13
Jesus Anampa: First-in-human trial targeting metastasis doorways in breast cancer
Insight
Nov 28, 2024, 17:10
Christian Rolfo: Amazing ISLB24 congress in summary
Opinion
Nov 28, 2024, 17:10
Ajay Major: BAFF-R CAR-T - Promising Outcomes in Refractory B-Cell Lymphomas
Blog
Nov 28, 2024, 16:34
Roni Shouval: Insights into Renal Injury in CAR-T Therapy from Global FDA Reports
Blog
Nov 28, 2024, 16:30
Ajay Major: Bridging Radiotherapy and Systemic Therapy - Impact on Outcomes Before Axi-Cel
Blog
Nov 28, 2024, 16:24
“Researchers ID key mechanism behind drug-resistant prostate cancer“ - Weill Cornell Medicine Pathology
Insight
Nov 28, 2024, 15:42
Novartis Kisqali Receives European Commission Approval for HR+/HER2- Early Breast Cancer at High Risk of Recurrence
Blog
Nov 28, 2024, 15:29
Honoring the Legacy of Faustine Ndugulile